What antibiotic should I use to treat this patient’s Klebsiella pneumoniae? It’s resistant to carbapenems, and there’s a ...
NEW DELHI -More than 80 per cent of Indian patients carry multidrug-resistant organisms (MDROs), the highest globally, according to an alarming study released on November 18. This reflects the deep ...
A one-dose oral drug called zoliflodacin has proven highly effective against gonorrhoea in a major international trial. The pill matched the success of current treatments while avoiding injections and ...
A promising drug combination could help people with leukemia who don't respond to traditional treatments, according to new research. A team at Oregon Health and Science University made the discovery ...
Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that ...
Michigan hospitals have noted a rise in a drug-resistant fungal infection in recent years. Candida auris was first identified in a resident in 2021. Since then, the state has confirmed more than 2,200 ...
Drug-resistant gonorrhoea is on the rise worldwide, but a new antibiotic could buy us more time before the emergence of completely untreatable strains of the bacteria, which is known to potentially ...
Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites seeding new resistant tumors elsewhere in the body. Combating the problem has ...
ABSTRACT: The emergence and spread of antibiotic-resistant bacteria constitute a major global public health threat, compromising treatment efficacy and increasing morbidity and mortality associated ...
ABSTRACT: The emergence and spread of antibiotic-resistant bacteria constitute a major global public health threat, compromising treatment efficacy and increasing morbidity and mortality associated ...
This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...
A phase 3 trial of Novartis’ next-generation malaria treatment has met its primary endpoint, positioning the drugmaker to seek approval of a therapy with the potential to kill drug-resistant parasites ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results